Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohns disease research[1].
Molecular Weight:
(144.66 kDa)
Purity:
99.49
CAS Number:
[219716-33-3]
Target:
Apoptosis
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
